(Q34544359)

2 August 2017

1 reference

title

Decreasing incidence of hepatocellular carcinoma among children following universal hepatitis B immunization (English)

1 reference

2 August 2017

0 references

hepatocellular carcinoma

1 reference

1 reference

1

Mei-Hwei Chang

0 references

publication date

1 October 2003

1 reference

2 August 2017

1 reference

2 August 2017

23

1 reference

2 August 2017

5

1 reference

2 August 2017

309-314

1 reference

Effect of interferon therapy on the incidence of hepatocellular carcinoma and mortality of patients with chronic hepatitis C: a retrospective cohort study of 738 patients

2 August 2017

1 reference

https://api.crossref.org/works/10.1034%2FJ.1478-3231.2003.00865.X

Chlorophyllin intervention reduces aflatoxin-DNA adducts in individuals at high risk for liver cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1478-3231.2003.00865.X

Curcumin-containing diet inhibits diethylnitrosamine-induced murine hepatocarcinogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1478-3231.2003.00865.X

Hepatitis B virus infection in children and adolescents in a hyperendemic area: 15 years after mass hepatitis B vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1478-3231.2003.00865.X

Observational study of vaccine efficacy 14 years after trial of hepatitis B vaccination in Gambian children

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1478-3231.2003.00865.X

Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. Taiwan Childhood Hepatoma Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1478-3231.2003.00865.X

Mercury concentrations and metabolism in infants receiving vaccines containing thiomersal: a descriptive study

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1478-3231.2003.00865.X

Early predictor of the efficacy of immunoprophylaxis against perinatal hepatitis B transmission: analysis of prophylaxis failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1478-3231.2003.00865.X

The role of transplacental hepatitis B core antibody in the mother-to-infant transmission of hepatitis B virus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1478-3231.2003.00865.X

New immunization initiatives and progress toward the global control of hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1478-3231.2003.00865.X

A mass vaccination program in Taiwan against hepatitis B virus infection in infants of hepatitis B surface antigen-carrier mothers

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1478-3231.2003.00865.X

Hepatitis B vaccination: universal vaccination of newborn babies and children at 12 years of age versus high risk groups. A comparison in the field

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1478-3231.2003.00865.X

Hepatitis B vaccination and hepatocellular carcinoma rates in boys and girls

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1478-3231.2003.00865.X

Hepatitis B vaccine and central nervous system demyelinating diseases. Viral Hepatitis Prevention Board

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1478-3231.2003.00865.X

Maternal transmission of hepatitis B virus in childhood hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1478-3231.2003.00865.X

7 January 2021

Hepatitis B virus integration in hepatitis B virus-related hepatocellular carcinoma in childhood

1 reference

https://api.crossref.org/works/10.1034%2FJ.1478-3231.2003.00865.X

7 January 2021

Maternal Transmission of Hepatitis B Surface Antigen in Patients with Hepatocellular Carcinoma in Taiwan

1 reference

https://api.crossref.org/works/10.1034%2FJ.1478-3231.2003.00865.X

7 January 2021

Prevention of perinatally transmitted hepatitis B virus infections with hepatitis B immune globulin and hepatitis B vaccine

1 reference

https://api.crossref.org/works/10.1034%2FJ.1478-3231.2003.00865.X

7 January 2021

A mass vaccination program in Taiwan against hepatitis B virus infection in infants of hepatitis B surface antigen-carrier mothers

1 reference

https://api.crossref.org/works/10.1034%2FJ.1478-3231.2003.00865.X

7 January 2021

Protective efficacy of a recombinant DNA hepatitis B vaccine in neonates of HBe antigen-positive mothers

1 reference

https://api.crossref.org/works/10.1034%2FJ.1478-3231.2003.00865.X

7 January 2021

Global status of hepatitis B immunisation

1 reference

https://api.crossref.org/works/10.1034%2FJ.1478-3231.2003.00865.X

7 January 2021

10.1034/J.1478-3231.2003.00865.X

Identifiers

DOI

1 reference

2 August 2017

1 reference

PubMed ID

14708890